Antibodies 2022 : Bioengineering Special Issue: Development of Therapeutic Antibodies for the Treatment of Diseases

Dear Colleagues,

Therapeutic antibodies have become the prevailing class of novel therapeutic drug candidates in recent years, due to their high specificity and fewer adverse effects. As a result, new antibody drugs have been developed to treat various human diseases, including cancers, infectious diseases, and autoimmune diseases, which has led to unprecedented growth in the pharmaceutical market.

This Special Issue covers the development of antibody drugs (or candidates), the latest advances in the discovery, engineering, validation, and manufacturing of therapeutic antibodies, and novel antibody-based therapeutic platforms, including bispecific-antibodies, single-domain antibodies, and antibody–drug conjugates. This Special Issue invites both original research and reviews.

Please contact Sophie Wang ([email protected]) if you have any questions.

Dr. Jung-Hyun Na
Dr. Tae Hyun Kang
Guest Editors